A Placebo-Controlled, Pseudo-Randomized, Crossover Trial of Botanical Agents for Gulf War Illness: Curcumin (Curcuma longa), Boswellia (Boswellia serrata), and French Maritime Pine Bark (Pinus pinaster)
- PMID: 33802272
- PMCID: PMC7967595
- DOI: 10.3390/ijerph18052468
A Placebo-Controlled, Pseudo-Randomized, Crossover Trial of Botanical Agents for Gulf War Illness: Curcumin (Curcuma longa), Boswellia (Boswellia serrata), and French Maritime Pine Bark (Pinus pinaster)
Abstract
This report is part of a larger study designed to rapidly and efficiently screen potential treatments for Gulf War Illness (GWI) by testing nine different botanicals. In this placebo-controlled, pseudo-randomized, crossover clinical trial of 20 men with GWI, we tested three botanical agents with putative peripheral and central anti-inflammatory actions: curcumin (Curcuma longa), boswellia (Boswellia serrata), and French maritime pine bark extract (Pinus pinaster). Participants completed 30 +/- 3 days of baseline symptom reports, followed by 30 +/- 3 days of placebo, 30 +/- 3 days of lower-dose botanical, and 30 +/- 3 days of higher-dose botanical. Participants then repeated the process with a new botanical until completing up to three botanical cycles. Data were analyzed using linear mixed models. Curcumin reduced GWI symptom severity significantly more than placebo at both the lower (p < 0.0001) and higher (p = 0.0003) dosages. Boswellia was not more effective than placebo at reducing GWI symptoms at either the lower (p = 0.726) or higher (p = 0.869) dosages. Maritime pine was not more effective than placebo at the lower dosage (p = 0.954) but was more effective than placebo at the higher dosage (p = 0.006). This study provides preliminary evidence that curcumin and maritime pine may help alleviate symptoms of GWI. As a screening study, a final determination of the efficacy of these compounds for all individuals with GWI cannot be made, and further studies will need to be conducted to determine strength and durability of effects, as well as optimal dosage. These results suggest that GWI may, at least in part, involve systemic inflammatory processes. This trial was registered on ClinicalTrials.gov (NCT02909686) on 13 September 2016.
Keywords: boswellia; curcumin; maritime pine.
Conflict of interest statement
The authors declare no conflict of interest.
Figures



Similar articles
-
Pycnogenol® French maritime pine bark extract in randomized, double-blind, placebo-controlled human clinical studies.Front Nutr. 2024 May 2;11:1389374. doi: 10.3389/fnut.2024.1389374. eCollection 2024. Front Nutr. 2024. PMID: 38757130 Free PMC article. Review.
-
A Placebo-Controlled, Pseudo-Randomized, Crossover Trial of Botanical Agents for Gulf War Illness: Resveratrol (Polygonum cuspidatum), Luteolin, and Fisetin (Rhus succedanea).Int J Environ Res Public Health. 2021 Mar 3;18(5):2483. doi: 10.3390/ijerph18052483. Int J Environ Res Public Health. 2021. PMID: 33802381 Free PMC article. Clinical Trial.
-
A Placebo-Controlled, Pseudo-Randomized, Crossover Trial of Botanical Agents for Gulf War Illness: Reishi Mushroom (Ganoderma lucidum), Stinging Nettle (Urtica dioica), and Epimedium (Epimedium sagittatum).Int J Environ Res Public Health. 2021 Apr 1;18(7):3671. doi: 10.3390/ijerph18073671. Int J Environ Res Public Health. 2021. PMID: 33915962 Free PMC article. Clinical Trial.
-
Pharmacokinetic assessment of constituents of Boswellia serrata, pine bark extracts, curcumin in combination including methylsulfonylmethane in healthy volunteers.J Pharm Pharmacol. 2020 Jan;72(1):121-131. doi: 10.1111/jphp.13184. Epub 2019 Oct 13. J Pharm Pharmacol. 2020. PMID: 31608447 Clinical Trial.
-
Pathophysiological basis and promise of experimental therapies for Gulf War Illness, a chronic neuropsychiatric syndrome in veterans.Psychopharmacology (Berl). 2023 Apr;240(4):673-697. doi: 10.1007/s00213-023-06319-5. Epub 2023 Feb 15. Psychopharmacology (Berl). 2023. PMID: 36790443 Review.
Cited by
-
Bioenergetic impairment in Gulf War illness assessed via 31P-MRS.Sci Rep. 2024 Mar 28;14(1):7418. doi: 10.1038/s41598-024-57725-4. Sci Rep. 2024. PMID: 38548808 Free PMC article.
-
Crisis in the gut: navigating gastrointestinal challenges in Gulf War Illness with bioengineering.Mil Med Res. 2024 Jul 8;11(1):45. doi: 10.1186/s40779-024-00547-2. Mil Med Res. 2024. PMID: 38978144 Free PMC article. Review.
-
Potential complementary and/or synergistic effects of curcumin and boswellic acids for management of osteoarthritis.Ther Adv Musculoskelet Dis. 2022 Sep 22;14:1759720X221124545. doi: 10.1177/1759720X221124545. eCollection 2022. Ther Adv Musculoskelet Dis. 2022. PMID: 36171802 Free PMC article. Review.
-
Pycnogenol® French maritime pine bark extract in randomized, double-blind, placebo-controlled human clinical studies.Front Nutr. 2024 May 2;11:1389374. doi: 10.3389/fnut.2024.1389374. eCollection 2024. Front Nutr. 2024. PMID: 38757130 Free PMC article. Review.
-
Curcumin Formulations for Better Bioavailability: What We Learned from Clinical Trials Thus Far?ACS Omega. 2023 Mar 13;8(12):10713-10746. doi: 10.1021/acsomega.2c07326. eCollection 2023 Mar 28. ACS Omega. 2023. PMID: 37008131 Free PMC article. Review.
References
-
- White R.F., Steele L., O’Callaghan J.P., Sullivan K., Binns J.H., Golomb B.A., Bloom F.E., Bunker J.A., Crawford F., Graves J.C., et al. Recent research on Gulf War illness and other health problems in veterans of the 1991 Gulf War: Effects of toxicant exposures during deployment. Cortex A J. Devoted Study Nerv. Syst. Behav. 2016;74:449–475. doi: 10.1016/j.cortex.2015.08.022. - DOI - PMC - PubMed
-
- Khaiboullina S.F., DeMeirleir K.L., Rawat S., Berk G.S., Gaynor-Berk R.S., Mijatovic T., Blatt N., Rizvanov A.A., Young S.G., Lombardi V.C. Cytokine expression provides clues to the pathophysiology of Gulf War illness and myalgic encephalomyelitis. Cytokine. 2015;72:1–8. doi: 10.1016/j.cyto.2014.11.019. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials